Mariam Keramati
Physical Medicine & Rehabilitation · Baltimore, MDNPI 1114217841
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 35.4% of the total.
Across 105 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$821
- Merz Pharmaceuticals, LLC$642
- Ipsen Biopharmaceuticals, Inc$148
- Merz North America, Inc.$143
- Biogen$134
- Averitas Pharma Inc.$54
- plus $381 from 16 others
What the payments were for
- Food & beverage$2,28999%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $821 |
| Merz Pharmaceuticals, LLC | 25 | $642 |
| Ipsen Biopharmaceuticals, Inc | 7 | $148 |
| Merz North America, Inc. | 4 | $143 |
| Biogen | 3 | $134 |
| Averitas Pharma Inc. | 2 | $54 |
| Microtransponder, Inc. | 1 | $42 |
| Relievant Medsystems, Inc. | 1 | $37 |
| Revance Therapeutics, Inc. | 1 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Si-bone, Inc. | 1 | $24 |
| Boston Scientific | 1 | $24 |
| SPR Therapeutics, Inc | 1 | $22 |
| Electronic Waveform Lab, Inc. | 2 | $22 |
| GRT US Holding, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Nalu Medical, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,321 in reported general payments places this provider in the 85th percentile of 202 physical medicine & rehabilitation providers in Maryland.
See all physical medicine & rehabilitation providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 54 | $2,826 |
| Baclofen | 81 | $2,626 |
| Duloxetine Hcl | 41 | $2,416 |
| Pregabalin | 27 | $957 |
| Tizanidine Hcl | 19 | $755 |
| Divalproex Sodium | 20 | $261 |
| Ropinirole Hcl | 12 | $239 |
| Oxycodone Hcl | 12 | $215 |
| Trazodone Hcl | 23 | $160 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Baltimore
- Akhil ChhatreBaltimore$169K
- Ronald ShinBaltimore$19K
- Mustafa BroachwalaBaltimore$17K
- Gerard LimerickBaltimore$12K
- Marisa FlavinBaltimore$5K
- Tae Hwan ChungBaltimore$3K
- Edward SorianoBaltimore$3K
- Scott BrownBaltimore$2K
- Eric BuchnerBaltimore$2K
- Paige HarrisonBaltimore$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.